UK Markets closed

MGC Pharmaceuticals Limited (MXC.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
3.6000-0.0320 (-0.88%)
At close: 6:52PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 579.45M
Enterprise value 361.52M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)76.13
Price/book (mrq)3,600.00
Enterprise value/revenue 358.95
Enterprise value/EBITDA 7-6.26

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3250.0000
52-week low 32.1750
50-day moving average 34.3147
200-day moving average 310.2383

Share statistics

Avg vol (3-month) 356.93M
Avg vol (10-day) 39.99M
Shares outstanding 52.28B
Implied shares outstanding 6N/A
Float 1.6B
% held by insiders 110.09%
% held by institutions 10.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)31 Dec 2020


Profit margin 0.00%
Operating margin (ttm)-974.14%

Management effectiveness

Return on assets (ttm)-58.25%
Return on equity (ttm)-414.10%

Income statement

Revenue (ttm)1.04M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-58.30%
Gross profit (ttm)174.66k
Net income avi to common (ttm)-12.88M
Diluted EPS (ttm)-0.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.54M
Total cash per share (mrq)0
Total debt (mrq)2.11M
Total debt/equity (mrq)202.73
Current ratio (mrq)0.55
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-9.91M
Levered free cash flow (ttm)-4.01M